Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02523313 |
|---|---|
| Brief Title: | Immunotherapy With Nivolumab or Nivolumab Plus Ipilimumab vs. Double Placebo for Stage IV Melanoma w. NED |
| First Submitted : | August 5, 2015 |
| First Submitted that Met QC Criteria : | August 11, 2015 |
| First Posted : | August 14, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 10, 2021 |
| Last Update Posted : | December 13, 2021 |